FDA Inspection
Aesica Pharmaceuticals GmbHAesica Pharmaceuticals GmbH – FDA Inspection, Aug 31, 2023
Record Details
This FDA Inspection record concerns Aesica Pharmaceuticals GmbH, with an inspection on August 31, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Aesica Pharmaceuticals GmbH
- Inspection Date
- August 31, 2023
- Product Type
- Drugs
View Company Profile
ID · d6a6b8a4-3554-44f8-9ad9-9207b154e97e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1277716
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Aesica Pharmaceuticals GmbH
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 30, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 2, 2016 | VAI | Center for Drug Evaluation and Research | New Drug Evaluation |
| June 20, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 8, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Aesica Pharmaceuticals GmbH
- FDA Inspection 1105950 - 2019-08-30
- FDA Inspection 994783 - 2016-12-02
- FDA Inspection 887354 - 2014-06-20
- FDA Inspection 759166 - 2011-11-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.